StemCell Institute's book value per share for the quarter that ended in Sep. 2024 was 円280.13.
During the past 12 months, StemCell Institute's average Book Value Per Share Growth Rate was 20.00% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 26.80% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 23.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.
During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of StemCell Institute was 28.90% per year. The lowest was 16.30% per year. And the median was 24.50% per year.
StemCell Institute's current price is 円1210.00. Its book value per share for the quarter that ended in Sep. 2024 was 円280.13. Hence, today's PB Ratio of StemCell Institute is 4.32.
During the past 7 years, the highest P/B Ratio of StemCell Institute was 17.60. The lowest was 4.14. And the median was 9.57.
Good Sign:
StemCell Institute stock PB Ratio (=4.57) is close to 5-year low of 4.24.
StemCell Institute Book Value per Share Historical Data
The historical data trend for StemCell Institute's Book Value per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of StemCell Institute's Book Value per Share
For the Biotechnology subindustry, StemCell Institute's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
StemCell Institute's PB Ratio Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, StemCell Institute's PB Ratio distribution charts can be found below:
* The bar in red indicates where StemCell Institute's PB Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.
StemCell Institute (TSE:7096) Book Value per Share Explanation
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
StemCell Institute Book Value per Share Related Terms
Thank you for viewing the detailed overview of StemCell Institute's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
StemCell Institute is engaged in Cell bank business that separates and stores cord blood for regenerative medicine. Cord blood is the baby's blood contained in the umbilical cord and placenta that connects mother and baby. In its umbilical cord blood storage business, upon receiving notification from customers who have contracted, umbilical cord blood collected at obstetric facilities throughout Japan is collected, transported to the company's own cell processing center within 48 hours, and it provides a service to store cells at ultra-low temperature after separating cells from blood.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSE:7096 has been successfully added to your 